期刊文献+

肺癌相关肿瘤标记物的临床应用 预览 被引量:2

Clinical application about lung cancer related tumor markers
在线阅读 下载PDF
收藏 分享 导出
摘要 目的探讨血清细胞角蛋白19片段(CYFRA21—1)、癌胚抗原(CEA)和神经特异性烯醇化酶(NSE)存肺癌中的表达及临床应用。方法选取411例肺癌患者,并分别根据病理分型分为鳞癌组、腺癌组、小细胞癌组;根据临床分期将tH,细胞肺癌分为Ⅰ/Ⅱ期组、Ⅲ期组、Ⅳ期组,将小细胞肺癌分为局限期组、广泛期组;根据治疗效果分为CR+PR组、SD组、PD组。另选取健康体检者201例作为对照组进行比较,并检测受试者的CYFRA21—1、CEA和NSE浓度。结果鳞癌组CYFRA21—1浓度为(9.15±1.83)ng/mL,高于其他组;腺癌组CEA浓度为(61.79±25.34)ng/mL,高于其他组;小细胞癌组NSE浓度为(39.45±5.20)ng/mL,高于其他组。Ⅳ期组NSCLC的CYFRA21—1、CEA和NSE浓度分别为(8.30±1.76)ng/mL(59.32±28.30)ng/mL(30.92±8.10)ng/mL,且均明显高于Ⅰ/Ⅱ期组与Ⅲ期组。广泛期组SCLC的CYFRA211、CEA和NSE浓度分别为(8.16±2.03)ng/mL(34.18±21.75)ng/mL、(44.13±2.59)ng/mL,且均明显高于局限期组。CR+PR组治疗后CY—FRA21-1、CEA和NSE浓度明显低于治疗前,PD组治疗后CYFRA21-1、CEA和NSE浓度明显高于治疗前,差异均有统计学意义(P〈0.05)。结论CYFRA21—1、CEA和NSE可用于辅助预测肺癌的病理类型、临床分期及评价疗效。 Objective To explore the expression of cytokeratin 19 fragment (CYFRA21-1), carcinoembry onic antigen (CEA) and neuron specific enolase (NSE) in lung cancer and clinical application. Methods Four hundred and eleven patients with lung cancer were divided into squamous carcinoma group, adenocar cinoma group, small-cell cancer group according to pathology type and clinical stage, they were divided in to I/IIstage group, III stage group, IV stage group; they were divided into CR± PR group, SD group, PD group according to therapeutic efficacy. 201 healthy people as control group, and tested the level of CYFRA21-1, CEA and NSE. Results The levels of CYFRA21-1 in squamous cell carcinoma group was (9. 15±1.83) ng/mL, which was higher than other groups, the levels of CEA in adenocarcinoma group was (61.79±25.34) ng/mL which was higher than other groups, the levels of NSE in small cell carcinoma group was (39.45±5.20) ng/mL, which was higher than other groups. The levels of CYFRA21-1, CEA, NSEin IV stage group were (8.30±1.76) ng/mL, (59.32±28.30) ng/mL, (30.92±8. 10) ng/mL re spectively ,and which were higher than I / II stage group and III stage group in non small-cell lung cancer (NSCLC). The levels of CYFRA21-1,CEA,NSE in extensive stage group were (8. 16±2.03) ng/mL, (34.18±21.75) ng/mL, (44.13!2.59) ng/mL, respectively,higher than limited stage group in small-cell lung cancer (SCLC). Compared with before therapy and after therapy, the levels of CYFRA21-1, CEA, NSE in CR+PR group were lower after therapy, but the levels of CYFRA21-1, CEA, NSE in PD group were higher after therapy. Conclusion CYFRA21-1, CEA, NSE maybe could assist to predict the pathology type, clinical stage and therapeutic efficacy for lung cancer.
作者 胡云辉 赵春樱 王若峥 HU Yun-hui, ZHAO Chun-ying, WANG Ruo-zheng (Department of Radiation Oncology , Affiliated Tumor Hospital, Xinjiang Medical Urumqi 830011, China)
出处 《新疆医科大学学报》 CAS 2013年第1期16-20,共5页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区科技支疆项目(201291171)
关键词 肺癌 CYFRA21-1 CEA NSE lung cancer cytokeratin 19 fragment (CYFRA21-1) carcinoembryonie antigen (CEA) neu ron specific enolase (NSE)
  • 相关文献

参考文献10

二级参考文献57

  • 1宋丽华 ,宋现让 ,刘美芹 ,张锡芹 ,郑莉 ,李秀菊 ,刘蒲香 .Ⅲ期Ⅳ期非小细胞肺癌预后影响因素分析[J].中华肿瘤杂志,2004,26(6):345-348. 被引量:17
  • 2宋丽华 ,宋现让 ,张锡芹 ,齐洁琳 ,李秀菊 ,田禾 ,步兵 .小细胞肺癌患者预后因素分析[J].中华肿瘤杂志,2004,26(7):413-416. 被引量:21
  • 3Swets JA. ROC analysis applied to the evaluation of medical imaging techniques. Invest Radiol, 1979, 14(2): 109-121. 被引量:1
  • 4Pujol JL, Grenier J, Daures JP, et al. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res, 1993, 53(1):61-66. 被引量:1
  • 5Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science, 2001, 293(5532): 1068-1070. 被引量:1
  • 6Bird A. DNA methylation de novo. Science, 1999, 286(5448): 2287-2288. 被引量:1
  • 7Sun NC, Edgington TD, Carpentier CL, et al. Immunohistochemical localization of carcinoembryonic antigen (CEA), CEA-S, and nonspecific cross-reacting antigen (NCA) in carcinomas of lung. Cancer, 1983, 52(9): 1632-1641. 被引量:1
  • 8Akoun GM, Scarna HM, Milleron BJ, et al. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest, 1985, 87(1): 39-43. 被引量:1
  • 9Gasser RW, Herold M, Muller-Holzner E, et al. Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma. Dtsch Med Wochenschr, 1988, 113(44): 1708-1713. 被引量:1
  • 10Mino N, Iio A, Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer, 1988, 62(4): 730-734. 被引量:1

共引文献57

同被引文献32

引证文献2

二级引证文献7

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈